Clinical practice guideline on diagnosis and treatment of hyponatraemia

European Journal of Endocrinology

Volumn 170, Issue 3, 2014, Pages

  Spasovski, Goce ^a   Vanholder, Raymond ^b   Allolio, Bruno ^c   Annane, Djillali ^d   Ball, Steve ^e   Bichet, Daniel ^f   Decaux, Guy ^g   Fenske, Wiebke ^c   Hoorn, Ewout J ^h   Ichai, Carole ⁱ   Joannidis, Michael ^j   Soupart, Alain ^g   Zietse, Robert ^h   Haller, Maria ^k   Van Der Veer, Sabine ^l   Van Biesen, Wim ^b   Nagler, Evi ^b  

^a University Hospital of Skopje   (Macedonia)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^g ERASME HOSPITAL   (Belgium)

^h ERASMUS MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITY HOSPITAL OF NICE   (France)

^j UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^k KH Elisabethinen Linz GmbH   (Austria)

^l ACADEMIC MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CONTRAST MEDIUM; CYCLOPHOSPHAMIDE; DESMOPRESSIN; GLUCOSE; GLYCINE; HTK SOLUTION; IMMUNOGLOBULIN; MALTOSE; MANNITOL; OXYTOCIN; SODIUM; SODIUM CHLORIDE; TERLIPRESSIN; THIAZIDE DIURETIC AGENT; UREA; VASOPRESSIN;

ADRENAL INSUFFICIENCY; CEREBRAL SALT WASTING; CLINICAL DECISION MAKING; CLINICAL FEATURE; CLINICAL PRACTICE; COMA; CONFUSION; CONSENSUS DEVELOPMENT; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EUROPE; EVIDENCE BASED MEDICINE; HEADACHE; HEART DISEASE; HEART FAILURE; HUMAN; HYPONATREMIA; HYPOTHYROIDISM; INAPPROPRIATE VASOPRESSIN SECRETION; INFORMATION PROCESSING; KIDNEY DISEASE; LIVER FAILURE; MEDICAL RESEARCH; MEDICAL SOCIETY; MEDICAL SPECIALIST; NAUSEA; NEPHROTIC SYNDROME; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RESPIRATORY DISTRESS; REVIEW; SEIZURE; SERUM OSMOLALITY; SODIUM BLOOD LEVEL; SOMNOLENCE; SYSTEMATIC REVIEW; VOMITING;

ADULT; ALGORITHMS; BLOOD GLUCOSE; BRAIN EDEMA; ENDOCRINOLOGY; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; HYPONATREMIA; INAPPROPRIATE ADH SYNDROME; INFUSIONS, INTRAVENOUS; INTENSIVE CARE; KIDNEY DISEASES; MALE; NEPHROLOGY; OSMOLAR CONCENTRATION; SALINE SOLUTION, HYPERTONIC; SODIUM; VASOPRESSINS;

EID: 84896285517     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-1020     Document Type: Review

References (247)

1. Nagler EV, Vanmassenhove J, van der Veer SN, Nistor I, Van Biesen W, Webster AC & Vanholder R. Diagnosis and treatment of hyponatraemia: a systematic review of clinical practice guidelines. Nephrology, Dialysis, Transplantation 2013 28 i385-i391. (doi:10.1093/ndt/gft139)
2. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE et al. AGREE II: advancing guideline development, reporting and evaluation in healthcare. Canadian Medical Association Journal 2010 182 E839-E842. (doi:10.1503/cmaj.090449)
3. Cross NB, Craig JC & Webster AC. Asking the right question and finding the right answers. Nephrology 2010 15 8-11. (doi:10.1111/j.1440-1797. 2009.01264.x)
4. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, Porter AC, Tugwell P, Moher D & Bouter LM. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Medical Research Methodology 2007 7 10. (doi:10.1186/1471-2288-7-10)
5. Higgins JPT, Altman DG & Sterne JAC. Assessing risk of bias in included studies. In Cochrane Handbook for Systematic Reviews of Interventions, Eds JPT Higgins & S Green, 2011 (Ch 8, Version 5.1.0. The Cochrane Collaboration).
6. Wells GA, Shea BJ, O'Connell D, Peterson J, Welch V, Losos M & Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Department of Epidemiology and Community Medicine, University of Ottawa, Canada. Retrieved from: www.ohri.ca/programs/ clinical-epidemiology/oxford.asp.
7. Whiting PF, Rutjes AWS, Westwood ME & Mallett S. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011 155 529-536. (doi:10.7326/0003-4819-155-8-201110180- 00009)
8. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ & GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008 336 924-926. (doi:10.1136/bmj.39489.470347.AD)
9. Shiffman RN, Dixon J, Brandt C, Essaihi A, Hsiao A, Michel G & O'Connell R. The GuideLine Implementability Appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation. BMC Medical Informatics and Decision Making 2005 5 23-30. (doi:10.1186/1472-6947-5-23)
10. Beukhof CM, Hoorn EJ, Lindemans J & Zietse R. Novel risk factors for hospital-acquired hyponatraemia: a matched case-control study. Clinical Endocrinology 2007 66 367-372. (doi:10.1111/j.1365-2265.2007.02741.x)
11. Upadhyay A, Jaber BL & Madias NE. Epidemiology of hyponatremia. Seminars in Nephrology 2009 29 227-238. (doi:10.1016/j.semnephrol.2009.03.004)
12. Verbalis JG. Disorders of body water homeostasis. Best Practice & Research. Clinical Endocrinology & Metabolism 2003 17 471-503. (doi:10.1016/S1521-690X(03)00049-6)
13. Renneboog B, Musch W, Vandemergel X, Manto MU & Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. American Journal of Medicine 2006 119 71.e1-71.e8. (doi:10.1016/j.amjmed.2005.09.026)
14. Gankam Kengne F, Andres C, Sattar L, Melot C & Decaux G. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM: Monthly Journal of the Association of Physicians 2008 101 583-588. (doi:10.1093/qjmed/ hcn061)
15. Hoorn EJ, Rivadeneira F, van Meurs JB, Ziere G, Stricker BH, Hofman A, Pols HA, Zietse R, Uitterlinden AG & Zillikens MC. Mild hyponatremia as a risk factor for fractures: the Rotterdam Study. Journal of Bone and Mineral Research 2011 26 1822-1828. (doi:10.1002/jbmr.380)
16. Verbalis JG, Barsony J, Sugimura Y, Tian Y, Adams DJ, Carter EA & Resnick HE. Hyponatremia-induced osteoporosis. Journal of Bone and Mineral Research 2010 25 554-563. (doi:10.1359/jbmr.090827)
17. Liamis G, Rodenburg EM, Hofman A, Zietse R, Stricker BH & Hoorn EJ.Electrolyte disorders in community subjects: prevalence and risk factors. American Journal of Medicine 2013 126 256-263. (doi:10.1016/j.amjmed.2012.06. 037)
18. Wald R, Jaber BL, Price LL, Upadhyay A & Madias NE. Impact of hospital-associated hyponatremia on selected outcomes. Archives of Internal Medicine 2010 170 294-302. (doi:10.1001/archinternmed.2009.513)
19. Hoorn EJ & Zietse R. Hyponatremia and mortality: moving beyond associations. American Journal of Kidney Diseases 2013 62 139-149. (doi:10.1053/j.ajkd.2012.09.019)
20. Bourque CW. Central mechanisms of osmosensation and systemic osmoregulation. Nature Reviews. Neuroscience 2008 9 519-531. (doi:10.1038/nrn2400)
21. Lechner SG, Markworth S, Poole K, Smith ES, Lapatsina L, Frahm S, May M, Pischke S, Suzuki M, Ibañez-Tallon I et al. The molecular and cellular identity of peripheral osmoreceptors. Neuron 2011 69 332-344. (doi:10.1016/j.neuron.2010.12.028)
22. Sharif Naeini R, Witty MF, Séguéla P & Bourque CW. An N-terminal variant of Trpv1 channel is required for osmosensory transduction. Nature Neuroscience 2006 9 93-98. (doi:10.1038/nn1614)
23. Ciura S & Bourque CW. Transient receptor potential vanilloid 1 is required for intrinsic osmoreception in organum vasculosum lamina terminalis neurons and for normal thirst responses to systemic hyperosmolality. Journal of Neuroscience 2006 26 9069-9075. (doi:10.1523/JNEUROSCI.0877-06.2006)
24. Norsk P. Influence of low- and high-pressure baroreflexes on vasopressin release in humans. Acta Endocrinologica 1989 121 (Suppl 1) 3-27.
25. Baylis PH. Posterior pituitary function in health and disease. Clinics in Endocrinology and Metabolism 1983 12 747-770. (doi:10.1016/S0300-595X(83)80063- 2)
26. Robertson GL. Thirst and vasopressin function in normal and disordered states of water balance. Journal of Laboratory and Clinical Medicine 1983 101 351-371. (Pubitemid 13164262)
27. Zhang Z & Bourque CW. Amplification of transducer gain by angiotensin II-mediated enhancement of cortical actin density in osmosensory neurons. Journal of Neuroscience 2008 28 9536-9544. (doi:10.1523/JNEUROSCI.1495-08.2008)
28. Robertson GL & Athar S. The interaction of blood osmolality and blood volume in regulating plasma vasopressin in man. Journal of Clinical Endocrinology and Metabolism 1976 42 613-620. (doi:10.1210/jcem-42-4-613)
29. Schwartz WB, Bennett W, Curelop S & Bartter FC. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. American Journal of Medicine 1957 23 529-542. (doi:10.1016/0002-9343(57)90224-3)
30. Turchin A, Seifter JL & Seely EW. Clinical problem-solving. Mind the gap. New England Journal of Medicine 2003 349 1465-1469. (doi:10.1056/ NEJMcps031078)
31. Hillier TA, Abbott RD & Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. American Journal of Medicine 1999 106 399-403. (doi:10.1016/S0002-9343(99)00055-8)
32. Aviram A, Pfau A, Czaczkes JW & Ullmann TD. Hyperosmolality with hyponatremia, caused by inappropriate administration of mannitol. American Journal of Medicine 1967 42 648-650. (doi:10.1016/0002-9343(67)90066-6)
33. Desmond J. Serum osmolality and plasma electrolytes in patients who develop dilutional hyponatremia during transurethral resection. Canadian Journal of Surgery 1970 13 116-121.
34. Carlotti AP, Bohn D, Mallie JP & Halperin ML. Tonicity balance, and not electrolyte-free water calculations, more accurately guides therapy for acute changes in natremia. Intensive Care Medicine 2001 27 921-924. (doi:10.1007/s001340100911)
35. Hoorn EJ, Carlotti AP, Costa LA, MacMahon B, Bohn G, Zietse R, Halperin ML & Bohn D. Preventing a drop in effective plasma osmolality to minimize the likelihood of cerebral edema during treatment of children with diabetic ketoacidosis. Journal of Pediatrics 2007 150 467-473. (doi:10.1016/j.jpeds.2006. 11.062)
36. Oster JR & Singer I. Hyponatremia, hyposmolality, and hypotonicity: tables and fables. Archives of Internal Medicine 1999 159 333-336. (doi:10.1001/archinte.159.4.333)
37. Brown MB, Haack KK, Pollack BP, Millard-Stafford M & McCarty NA. Low abundance of sweat duct Cl- channel CFTR in both healthy and cystic fibrosis athletes with exceptionally salty sweat during exercise. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2011 300 R605-R615. (doi:10.1152/ajpregu.00660.2010)
38. Friedman E, Shadel M, Halkin H & Farfel Z. Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis. Annals of Internal Medicine 1989 110 24-30. (doi:10.7326/0003- 4819-110-1-24)
39. Sonnenblick M, Friedlander Y & Rosin AJ. Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest 1993 103 601-606. (doi:10.1378/chest.103.2.601)
40. Soule S. Addison's disease in Africa - a teaching hospital experience. Clinical Endocrinology 1999 50 115-120. (doi:10.1046/j.1365-2265.1999.00625.x)
41. Berendes E, Walter M, Cullen P, Prien T, Van Aken H, Horsthemke J, Schulte M, von Wild K & Scherer R. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet 1997 349 245-249. (doi:10.1016/S0140-6736(96)08093-2)
42. Sherlock M, O'Sullivan E, Agha A, Behan LA, Rawluk D, Brennan P, Tormey W & Thompson CJ. The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage. Clinical Endocrinology 2006 64 250-254. (doi:10.1111/j.1365-2265.2006.02432.x)
43. Hamdi T, Latta S, Jallad B, Kheir F, Alhosaini MN & Patel A. Cisplatin-induced renal salt wasting syndrome. Southern Medical Journal 2010 103 793-799. (doi:10.1097/SMJ.0b013e3181e63682)
44. Feldman BJ, Rosenthal SM, Vargas GA, Fenwick RG, Huang EA, Matsuda-Abedini M, Lustig RH, Mathias RS, Portale AA, Miller WL et al. Nephrogenic syndrome of inappropriate antidiuresis. New England Journal of Medicine 2005 352 1884-1890. (doi:10.1056/NEJMoa042743)
45. Ellison DH & Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. New England Journal of Medicine 2007 356 2064-2072. (doi:10.1056/NEJMcp066837)
46. Verbalis JG. Whole-body volume regulation and escape from antidiuresis. American Journal of Medicine 2006 119 S21-S29. (doi:10.1016/j.amjmed.2006.05. 004)
47. Tian W, Fu Y, Garcia-Elias A, Fernández-Fernández JM, Vicente R, Kramer PL, Klein RF, Hitzemann R, Orwoll ES, Wilmot B et al. A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia. PNAS 2009 106 14034-14039. (doi:10.1073/pnas.0904084106)
48. Faustini-Fustini M & Anagni M. Beyond semantics: defining hyponatremia in secondary adrenal insufficiency. Journal of Endocrinological Investigation 2006 29 267-269.
49. Kilpatrick ES. Disorders of sodium balance: hypothyroidism and hyponatraemia: an old wives' tale? BMJ 2006 332 854. (doi:10.1136/bmj.332.7545. 854)
50. Warner MH, Holding S & Kilpatrick ES. The effect of newly diagnosed hypothyroidism on serum sodium concentrations: a retrospective study. Clinical Endocrinology 2006 64 598-599. (doi:10.1111/j.1365-2265.2006.02489.x)
51. Curtis RH. Hyponatremia in primary myxedema. Annals of Internal Medicine 1956 44 376-385. (doi:10.7326/0003-4819-44-2-376)
52. Musch W, Xhaet O & Decaux G. Solute loss plays a major role in polydipsia-related hyponatraemia of both water drinkers and beer drinkers. QJM : Monthly Journal of the Association of Physicians 2003 96 421-426. (doi:10.1093/qjmed/hcg078)
53. Thaler SM, Teitelbaum I & Berl T. "Beer potomania" in non-beer drinkers: effect of low dietary solute intake. American Journal of Kidney Diseases 1998 31 1028-1031. (doi:10.1053/ajkd.1998.v31.pm9631849)
54. Gradden CW, Ahmad R & Bell GM. Peritoneal dialysis: new developments and new problems. Diabetic Medicine 2001 18 360-363. (doi:10.1046/j.1464-5491. 2001.00455.x)
55. Gheorghiade M, Abraham WT, Albert NM, Gattis Stough W, Greenberg BH, O'Connor CM, She L, Yancy CW, Young J, Fonarow GC et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. European Heart Journal 2007 28 980-988. (doi:10.1093/eurheartj/ehl542)
56. Goldberg A, Hammerman H, Petcherski S, Nassar M, Zdorovyak A, Yalonetsky S, Kapeliovich M, Agmon Y, Beyar R, Markiewicz W et al. Hyponatremia and long-term mortality in survivors of acute ST-elevation myocardial infarction. Archives of Internal Medicine 2006 166 781-786. (doi:10.1001/archinte.166.7.781)
57. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E & Therneau TM. Hyponatremia and mortality among patients on the liver-transplant waiting list. New England Journal of Medicine 2008 359 1018-1026. (doi:10.1056/NEJMoa0801209)
58. Hoorn EJ & Zietse R. Hyponatremia and mortality: how innocent is the bystander? Clinical Journal of the American Society of Nephrology 2011 6 951-953. (doi:10.2215/CJN.01210211)
59. Goland S, Naugolny V, Korbut Z, Rozen I, Caspi A & Malnick S. Appropriateness and complications of the use of spironolactone in patients treated in a heart failure clinic. European Journal of Internal Medicine 2011 22 424-427. (doi:10.1016/j.ejim.2011.04.008)
60. Wang SJ, Tsau YK, Lu FL & Chen CH. Hypovolemia and hypovolemic shock in children with nephrotic syndrome. Acta Paediatrica Taiwanica 2000 41 179-183.
61. Hoorn EJ, Lindemans J & Zietse R. Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrology, Dialysis, Transplantation 2006 21 70-76. (doi:10.1093/ndt/gfi082)
62. Waikar SS, Mount DB & Curhan GC. Mortality after hospitalization with mild, moderate, and severe hyponatremia. American Journal of Medicine 2009 122 857-865. (doi:10.1016/j.amjmed.2009.01.027)
63. Doshi SM, Shah P, Lei X, Lahoti A & Salahudeen AK. Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes. American Journal of Kidney Diseases 2012 59 222-228. (doi:10.1053/j.ajkd.2011.08.029)
64. Sterns RH. Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases. Annals of Internal Medicine 1987 107 656-664. (doi:10.7326/0003-4819-107-5-656)
65. Gill G, Huda B, Boyd A, Skagen K, Wile D, Watson I & van Heyningen C. Characteristics and mortality of severe hyponatraemia - a hospital-based study. Clinical Endocrinology 2006 65 246-249. (doi:10.1111/j.1365-2265.2006.02583.x)
66. Arieff AI, Llach F & Massry SG. Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine 1976 55 121-129. (doi:10.1097/00005792-197603000-00002)
67. Halberthal M, Halperin ML & Bohn D. Lesson of the week: acute hyponatraemia in children admitted to hospital: retrospective analysis of factors contributing to its development and resolution. BMJ 2001 322 780-782. (doi:10.1136/bmj.322.7289.780)
68. Darmon M, Diconne E, Souweine B, Ruckly S, Adrie C, Azoulay E, Clec'h C, Garrouste-Orgeas M, Schwebel C, Goldgran-Toledano D et al. Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change. Critical Care 2013 17 R12. (doi:10.1186/cc11937)
69. Funk GC, Lindner G, Druml W, Metnitz B, Schwarz C, Bauer P & Metnitz PG. Incidence and prognosis of dysnatremias present on ICU admission. Intensive Care Medicine 2010 36 304-311. (doi:10.1007/s00134-009-1692-0)
70. Sakr Y, Rother S, Ferreira AMP, Ewald C, Dünisch P, Riedemmann N & Reinhart K. Fluctuations in serum sodium level are associated with an increased risk of death in surgical ICU patients. Critical Care Medicine 2013 41 133-142. (doi:10.1097/CCM.0b013e318265f576)
71. Stelfox HT, Ahmed SB, Khandwala F, Zygun D, Shahpori R & Laupland K. The epidemiology of intensive care unit-acquired hyponatraemia and hypernatraemia in medical - surgical intensive care units. Critical Care 2008 12 R162. (doi:10.1186/cc7162)
72. Pirzada NA & Ali II. Central pontine myelinolysis. Mayo Clinic Proceedings 2001 76 559-562. (doi:10.4065/76.5.559)
73. Arieff AI. Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women. New England Journal of Medicine 1986 314 1529-1535. (doi:10.1056/NEJM198606123142401)
74. Ayus JC, Wheeler JM & Arieff AI. Postoperative hyponatremic encephalopathy in menstruant women. Annals of Internal Medicine 1992 117 891-897. (doi:10.7326/0003-4819-117-11-891)
75. Nzerue CM, Baffoe-Bonnie H, You W, Falana B & Dai S. Predictors of outcome in hospitalized patients with severe hyponatremia. Journal of the National Medical Association 2003 95 335-343. (Pubitemid 37101953)
76. Arieff AI, Ayus JC & Fraser CL. Hyponatraemia and death or permanent brain damage in healthy children. BMJ 1992 304 1218-1222. (doi:10.1136/bmj.304. 6836.1218)
77. Verbalis JG, Drutarosky MD, Ertel RJ & Vollmer RR. Adaptive responses to sustained volume expansion in hyponatraemic rats. Journal of Endocrinology 1989 122 421-431. (doi:10.1677/joe.0.1220421)
78. Verbalis JG & Gullans SR. Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats. Brain Research 1991 567 274-282. (doi:10.1016/0006- 8993(91)90806-7)
79. Sterns RH & Silver SM. Brain volume regulation in response to hypoosmolality and its correction. American Journal of Medicine 2006 119 S12-S16. (doi:10.1016/j.amjmed.2006.05.003)
80. Melton JE, Patlak CS, Pettigrew KD & Cserr HF. Volume regulatory loss of Na, Cl, and K from rat brain during acute hyponatremia. American Journal of Physiology 1987 252 F661-F669.
81. Sterns RH, Thomas DJ & Herndon RM. Brain dehydration and neurologic deterioration after rapid correction of hyponatremia. Kidney International 1989 35 69-75. (doi:10.1038/ki.1989.9)
82. Verbalis JG & Martinez AJ. Neurological and neuropathological sequelae of correction of chronic hyponatremia. Kidney International 1991 39 1274-1282. (doi:10.1038/ki.1991.161)
83. Videen JS, Michaelis T, Pinto P & Ross BD. Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study. Journal of Clinical Investigation 1995 95 788-793. (doi:10.1172/JCI117728)
84. Hoorn EJ & Zietse R. Hyponatremia revisited: translating physiology to practice. Nephron. Physiology 2008 108 46-59. (doi:10.1159/000119709)
85. Hsu Y-J, Chiu J-S, Lu K-C, Chau T & Lin S-H. Biochemical and etiological characteristics of acute hyponatremia in the emergency department. Journal of Emergency Medicine 2005 29 369-374. (doi:10.1016/j.jemermed.2005.02. 014)
86. Sterns RH. Treating hyponatremia: why haste makes waste. Southern Medical Journal 1994 87 1283-1287. (doi:10.1097/00007611-199412000-00016)
87. Adrogue HJ & Madias NE. Hyponatremia. New England Journal of Medicine 2000 342 1581-1589. (doi:10.1056/NEJM200005253422107)
88. Hoorn EJ, Halperin ML & Zietse R. Diagnostic approach to a patient with hyponatraemia: traditional versus physiology-based options. QJM: Monthly Journal of the Association of Physicians 2005 98 529-540. (doi:10.1093/qjmed/ hci081)
89. Chung HM, Kluge R, SchrierRW& Anderson RJ. Clinical assessment of extracellular fluid volume in hyponatremia. American Journal of Medicine 1987 83 905-908. (doi:10.1016/0002-9343(87)90649-8)
90. McGee S, Abernethy WB III & Simel DL. The rational clinical examination. Is this patient hypovolemic? Journal of the American Medical Association 1999 281 1022-1029. (doi:10.1001/jama.281.11.1022)
91. Bhave G & Neilson EG. Body fluid dynamics: back to the future. Journal of the American Society of Nephrology 2011 22 2166-2181. (doi:10.1681/ASN.2011080865)
92. Sunderrajan S, Bauer JH, Vopat RL, Wanner-Barjenbruch P & Hayes A. Posttransurethral prostatic resection hyponatremic syndrome: case report and review of the literature. American Journal of Kidney Diseases 1984 4 80-84. (Pubitemid 14034343)
93. Ryder KW, Olson JF, Kahnoski RJ, Karn RC & Oei TO. Hyperammonemia after transurethral resection of the prostate: a report of 2 cases. Journal of Urology 1984 132 995-997. (Pubitemid 14023526)
94. Haringhuizen A, Tjan DHT, Grool A, van Vugt R & van Zante ARH. Fatal cerebral oedema in adult diabetic ketoacidosis. Netherlands Journal of Medicine 2010 68 35-37.
95. Overlack A, Niederle N, Klautke G, Stumpe KO & Kruck F. Pseudohyponatremia in multiple myeloma. Klinische Wochenschrift 1980 58 875-880. (doi:10.1007/BF01476999)
96. Lawn N, Wijdicks EF & Burritt MF. Intravenous immune globulin and pseudohyponatremia. New England Journal of Medicine 1998 339 632. (doi:10.1056/NEJM199808273390914)
97. Lai M-Y, Lin C-C, Chung S-L, Wu C-H, Yang W-C & Tseng Y-T. Milky plasma, diabetes, and severe hyponatremia. Kidney International 2009 75 996. (doi:10.1038/ki.2008.335)
98. Dhatt G, Talor Z & Kazory A. Direct ion-selective electrode method is useful in diagnosis of pseudohyponatremia. Journal of Emergency Medicine 2012 43 348-349. (doi:10.1016/j.jemermed.2011.07.021)
99. Ladenson JH, Apple FS, Aguanno JJ & Koch DD. Sodium measurements in multiple myeloma: two techniques compared. Clinical Chemistry 1982 28 2383-2386. (Pubitemid 13217626)
100. Loughrey CM, Hanna EV, McDonnell M & Archbold GP. Sodium measurement: effects of differing sampling and analytical methods. Annals of Clinical Biochemistry 2006 43 488-493. (doi:10.1258/000456306778904560)
101. Kumar S & Berl T. Sodium. Lancet 1998 352 220-228. (doi:10.1016/S0140-6736(97)12169-9)
102. Smith DM, McKenna K & Thompson CJ. Hyponatraemia. Clinical Endocrinology 2000 52 667-678. (doi:10.1046/j.1365-2265.2000.01027.x)
103. Musch W, Thimpont J, Vandervelde D, Verhaeverbeke I, Berghmans T & Decaux G. Combined fractional excretion of sodium and urea better predicts response to saline in hyponatremia than do usual clinical and biochemical parameters. American Journal of Medicine 1995 99 348-355. (doi:10.1016/S0002- 9343(99)80180-6)
104. Fenske W, Maier SKG, Blechschmidt A, Allolio B & Stork S. Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study. American Journal of Medicine 2010 123 652-657. (doi:10.1016/j.amjmed.2010.01.013)
105. Hariprasad MK, Eisinger RP, Nadler IM, Padmanabhan CS & Nidus BD. Hyponatremia in psychogenic polydipsia. Archives of Internal Medicine 1980 140 1639-1642. (doi:10.1001/archinte.1980.00330230085018)
106. List AF, Hainsworth JD, Davis BW, Hande KR, Greco FA & Johnson DH. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer. Journal of Clinical Oncology 1986 4 1191-1198. (Pubitemid 16043869)
107. Fenske W, Stork S, Koschker AC, Blechschmidt A, Lorenz D, Wortmann S & Allolio B. Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics. Journal of Clinical Endocrinology and Metabolism 2008 93 2991-2997. (doi:10.1210/jc.2008-0330)
108. Musch W & Decaux G. Utility and limitations of biochemical parameters in the evaluation of hyponatremia in the elderly. International Urology and Nephrology 2001 32 475-493. (doi:10.1023/A:1017586004688)
109. Hato T & Ng R. Diagnostic value of urine sodium concentration in hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion versus hypovolemia. Hawaii Medical Journal 2010 69 264-267.
110. Fenske W, Stork S, Blechschmidt A, Maier SG, Morgenthaler NG & Allolio B. Copeptin in the differential diagnosis of hyponatremia. Journal of Clinical Endocrinology and Metabolism 2009 94 123-129. (doi:10.1210/jc.2008- 1426)
111. Hamburger S, Koprivica B, Ellerbeck E & Covinsky JO. Thiazide-induced syndrome of inappropriate secretion of antidiuretic hormone. Time course of resolution. Journal of the American Medical Association 1981 246 1235-1236. (doi:10.1001/jama.1981.03320110047028)
112. Schrier RW. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy. New England Journal of Medicine 1988 319 1127-1134. (doi:10.1056/ NEJM198810273191705)
113. Joyce SM & Potter R. Beer potomania: an unusual cause of symptomatic hyponatremia. Annals of Emergency Medicine 1986 15 745-747. (doi:10.1016/S0196- 0644(86)80442-5)
114. Spital A. Hyponatremia in adrenal insufficiency: review of pathogenetic mechanisms. Southern Medical Journal 1982 75 581-585. (doi:10.1097/00007611- 198205000-00018)
115. Arlt W & Allolio B. Adrenal insufficiency. Lancet 2003 361 1881-1893. (doi:10.1016/S0140-6736(03)13492-7)
116. Almiani M, Gorthi J, Subbiah S & Firoz M. Quiz page november: an unusual case of acute hyponatremia and normal anion gap metabolic acidosis. American Journal of Kidney Diseases 2012 60 xxxiii-xxxvi. (doi:10.1053/j.ajkd. 2012.05.026)
117. Smith JC, Siddique H & Corrall RJM. Misinterpretation of serum cortisol in a patient with hyponatraemia. BMJ 2004 328 215-216. (doi:10.1136/bmj.328.7433.215)
118. van der Hoek J, Hoorn EJ, de Jong GMT, Janssens ENW & de Herder WW. Severe hyponatremia with high urine sodium and osmolality. Clinical Chemistry 2009 55 1905-1908. (doi:10.1373/clinchem.2009.125575)
119. Worthley LI & Thomas PD. Treatment of hyponatraemic seizures with intravenous 29.2% saline. BMJ 1986 292 168-170. (doi:10.1136/bmj.292.6514.168)
120. Ayus JC, Olivero JJ & Frommer JP. Rapid correction of severe hyponatremia with intravenous hypertonic saline solution. American Journal of Medicine 1982 72 43-48. (doi:10.1016/0002-9343(82)90575-7)
121. Woo CH, Rao VA, Sheridan W & Flint AC. Performance characteristics of a sliding-scale hypertonic saline infusion protocol for the treatment of acute neurologic hyponatremia. Neurocritical Care 2009 11 228-234. (doi:10.1007/s12028-009-9238-4)
122. Mohmand HK, Issa D, Ahmad Z, Cappuccio JD, Kouides RW & Sterns RH. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection. Clinical Journal of the American Society of Nephrology 2007 2 1110-1117. (doi:10.2215/CJN.00910207)
123. Forssell G, Nordlander R & Orinius E. Treatment of dilutional hyponatremia in congestive heart failure. Acta Medica Scandinavica 1980 207 279-281. (doi:10.1111/j.0954-6820.1980.tb09721.x)
124. Musch W & Decaux G. Treating the syndrome of inappropriate ADH secretion with isotonic saline. QJM: Monthly Journal of the Association of Physicians 1998 91 749-753. (doi:10.1093/qjmed/91.11.749)
125. Castello L, Pirisi M, Sainaghi PP & Bartoli E. Quantitative treatment of the hyponatremia of cirrhosis. Digestive and Liver Disease 2005 37 176-180. (doi:10.1016/j.dld.2004.10.008)
126. Bhaskar E, Kumar B & Ramalakshmi S. Evaluation of a protocol for hypertonic saline administration in acute euvolemic symptomatic hyponatremia: a prospective observational trial. Indian Journal of Critical Care Medicine 2010 14 170-174. (doi:10.4103/0972-5229.76079)
127. Sood L, Sterns RH, Hix JK, Silver SM & Chen L. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia. American Journal of Kidney Diseases 2013 61 571-578. (doi:10.1053/j.ajkd.2012. 11.032)
128. Cluitmans FH & Meinders AE. Management of severe hyponatremia: rapid or slow correction? American Journal of Medicine 1990 88 161-166. (doi:10.1016/0002-9343(90)90467-R)
129. Abbott R, Silber E, Felber J & Ekpo E. Osmotic demyelination syndrome. BMJ 2005 331 829-830. (doi:10.1136/bmj.331.7520.829)
130. Berl T & Rastegar A. A patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion. American Journal of Kidney Diseases 2010 55 742-748. (doi:10.1053/j.ajkd.2009.12.024)
131. Biotti D & Durupt D. A trident in the brain, central pontine myelinolysis. Practical Neurology 2009 9 231-232. (doi:10.1136/jnnp.2009.182469)
132. Calakos N, Fischbein N, Baringer JR & Jay C. Cortical MRI findings associated with rapid correction of hyponatremia. Neurology 2000 55 1048-1051. (doi:10.1212/WNL.55.7.1048)
133. Charra B, Hachimi A, Guedari H, Benslama A & Motaouakkil S. Extrapontine myelinolysis after correction of hyponatremia. Annales Françaises d'Anesthésie-Réanimation 2006 25 76-77. (doi:10.1016/j.annfar.2005.08.013)
134. Chuang YC, Chang CS, Hsu SP, Lin TK & Lui CC. Osmotic demyelination syndrome with two-phase movement disorders: case report. Changgeng Yi Xue Za Zhi 1998 21 526-530.
135. Deleu D, Salim K, Mesraoua B, El Siddig A, Al Hail H & Hanssens Y. "Man-in-the-barrel" syndrome as delayed manifestation of extrapontine and central pontine myelinolysis: beneficial effect of intravenous immunoglobulin. Journal of Neurological Sciences 2005 237 103-106. (doi:10.1016/j.jns.2005.05.012)
136. Dellabarca C, Servilla KS, Hart B, Murata GH & Tzamaloukas AH. Osmotic myelinolysis following chronic hyponatremia corrected at an overall rate consistent with current recommendations. International Urology and Nephrology 2005 37 171-173. (doi:10.1007/s11255-004-4770-9)
137. Georgy V, Mullhi D & Jones AF. Central pontine myelinolysis following 'optimal' rate of correction of hyponatraemia with a good clinical outcome. Annals of Clinical Biochemistry 2007 44 488-490. (doi:10.1258/ 000456307781646067)
138. Gregorio L, Sutton CL & Lee DA. Central pontine myelinolysis in a previously healthy 4-year-old child with acute rotavirus gastroenteritis. Pediatrics 1997 99 738-743. (doi:10.1542/peds.99.5.738)
139. Hawthorne KM, Compton CJ, Vaphiades MS, Roberson GH & Kline LB. Ocular motor and imaging abnormalities of midbrain dysfunction in osmotic demyelination syndrome. Journal of Neuro-Ophthalmology 2009 29 296-299. (doi:10.1097/WNO.0b013e3181c25390)
140. Howard SA, Barletta JA, Klufas RA, Saad A & De Girolami U. Best cases from the AFIP: osmotic demyelination syndrome. Radiographics 2009 29 933-938. (doi:10.1148/rg.293085151)
141. Hsieh C-Y & Huang C-W. Extrapontine myelinolysis in a patient following correction of hyponatremia. Acta Neurologica Belgica 2007 16 188-189. (Pubitemid 47555763)
142. Imoto S, Takeda A, Koyama K, Taguchi S, Horibe K & Nakamura H. Late occurrence of severe hyponatremia followed by extrapontine osmotic demyelination syndrome after successful conservative management of postpartum hemorrhage due to placenta accreta by uterine artery embolization. Journal of Maternal-Fetal & Neonatal Medicine 2010 23 742-746. (doi:10.3109/14767050903265097)
143. Kelly J, Wassif W, Mitchard J & Gardner WN. Severe hyponatraemia secondary to beer potomania complicated by central pontine myelinolysis. International Journal of Clinical Practice 1998 52 585-587. (Pubitemid 28561133)
144. Kumar SR, Mone AP, Gray LC & Troost BT. Central pontine myelinolysis: delayed changes on neuroimaging. Journal of Neuroimaging 2000 10 169-172. (Pubitemid 30463953)
145. Laureno R & Karp BI. Myelinolysis after correction of hyponatremia. Annals of Internal Medicine 1997 126 57-62. (doi:10.7326/0003-4819-126-1- 199701010-00008)
146. Lawson B & Silva J. Central pontine myelinolysis and hyponatremia. Clinical case. Revista Medica de Chile 2001 129 427-432.
147. Leens C, Mukendi R, Foret F, Hacourt A, Devuyst O & Colin IM. Central and extrapontine myelinolysis in a patient in spite of a careful correction of hyponatremia. Clinical Nephrology 2001 55 248-253. (Pubitemid 32218992)
148. Lin C-M & Po HL. Extrapontine myelinolysis after correction of hyponatremia presenting as generalized tonic seizures. American Journal of Emergency Medicine 2008 26 632.e635-632.e636.
149. Lin S-H, Chau T, Wu C-C & Yang S-S. Osmotic demyelination syndrome after correction of chronic hyponatremia with normal saline. American Journal of the Medical Sciences 2002 323 259-262. (doi:10.1097/00000441-200205000-00005)
150. Mauri MC, Volonteri LS, Fiorentini A, Dieci M, Righini A & Vita A. Efficacy of clozapine in a non-schizophrenic patient with psychogenic polydipsia and central pontine myelinolysis. Human Psychopharmacology 2002 17 253-255. (doi:10.1002/hup.407)
151. Moore K & Midha M. Extra pontine myelinolysis in a tetraplegic
152. Nagamitsu S, Matsuishi T, Yamashita Y, Yamada S & Kato H. Extrapontine myelinolysis with parkinsonism after rapid correction of hyponatremia: high cerebrospinal fluid level of homovanillic acid and successful dopaminergic treatment. Journal of Neural Transmission 1999 106 949-953. (doi:10.1007/s007020050215)
153. Odier C, Nguyen DK & Panisset M. Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis. Journal of Neurology 2010 257 1176-1180. (doi:10.1007/s00415-010-5486-7)
154. Ojeda Burgos G, Cuenca A, de la Cruz Cosme C, Pérez E, Vicioso L, Aguilar R & Rivas E. Confusional syndrome in a patient with severe hyponatremia. Revista Clínica Española 2008 208 49-51. (doi:10.1157/13115008)
155. Okada K, Nomura M, Furusyo N, Otaguro S, Nabeshima S & Hayashi J. Amelioration of extrapontine myelinolysis and reversible parkinsonism in a patient with asymptomatic hypopituitarism. Internal Medicine 2005 44 739-742. (doi:10.2169/internalmedicine.44.739)
156. Pekic S, Doknic M, Miljic D, Saveanu A, Reynaud R, Barlier A, Brue T & Popovic V. Case seminar: a young female with acute hyponatremia and a sellar mass. Endocrine 2011 40 325-331. (doi:10.1007/s12020-011-9516-8)
157. Pietrini V, Mozzani F, Crafa P, Sivelli R, Cademartiri F & Crisi G. Central pontine and extrapontine myelinolysis despite careful correction of hyponatremia: clinical and neuropathological findings of a case. Neurological Sciences 2010 31 227-230. (doi:10.1007/s10072-009-0173-0)
158. Ranger A, Szymczak A, Levin S, Salvadori M & Fraser DD. Osmotic myelinolysis with malignant cerebellar edema occurring after DDAVP-induced hyponatremia in a child. Pediatric Neurosurgery 2010 46 318-323. (doi:10.1159/000320146)
159. Ruiz S, Alzieu M, Niquet L, Vergne S, Lathuile D & Campistron J. Severe hyponatraemia and central pontine myelinolysis: be careful with other factors!. Annales Françaises d'Anesthésie-Réanimation 2009 28 96-99. (doi:10.1016/j.annfar.2008.11.010)
160. Salvesen R. Extrapontine myelinolysis after surgical removal of a pituitary tumour. Acta Neurologica Scandinavica 1998 98 213-215. (doi:10.1111/j.1600-0404.1998.tb07297.x)
161. Schuster M, Diekmann S, Klingebiel R & Volk T. Central pontine myelinolysis despite slow sodium rise in a case of severe community-acquired hyponatraemia. Anaesthesia and Intensive Care 2009 37 117-120.
162. Seok JI, Lee DK, Kang MG & Park JH. Neuropsychological findings of extrapontine myelinolysis without central pontine myelinolysis. Behavioural Neurology 2007 18 131-134. (doi:10.1155/2007/980643)
163. Serrano-Castro PJ, Alonso-Verdegay G, Lopez-Martinez G, Arjona-Padillo A, Callejón JR, Olmedo VM, Guardado-Santervás P, Huete-Hurtado A, Olivares-Romero J & Fernández CN. Possible case of peripheral osmotic demyelination syndrome. Journal of Neurology, Neurosurgery, and Psychiatry 2008 79 331-332. (doi:10.1136/jnnp.2007.125625)
164. Shah VR, Parikh GP & Bhosale G. Central pontine myelinolysis: sequele of hyponatremia during transcervical resection of endometrium. Acta Anaesthesiologica Scandinavica 2002 46 914-916. (doi:10.1034/j.1399-6576.2002. 460727.x)
165. Singer C, Lorenzo D, Papapetropoulos S, Mesa A & Bowen B. Pontine/extrapontine myelinolysis occurring in the setting of an eating disorder. Neurology 2005 64 2156-2157. (doi:10.1212/01.WNL.0000166028.77179.1F)
166. Snell DM & Bartley C. Osmotic demyelination syndrome following rapid correction of hyponatraemia. Anaesthesia 2008 63 92-95. (doi:10.1111/j.1365- 2044.2007.05341.x)
167. Spengos K, Vassilopoulou S, Tsivgoulis G, Dimitrakopoulos A, Toulas P & Vassilapoulos D. Hyponatraemia and central pontine myelinolysis after elective colonoscopy. European Journal of Neurology 2005 12 322-323. (doi:10.1111/j.1468-1331.2004.00991.x)
168. Sullivan AA, Chervin RD & Albin RL. Parkinsonism after correction of hyponatremia with radiological central pontine myelinolysis and changes in the basal ganglia. Journal of Clinical Neuroscience 2000 7 256-259. (doi:10.1054/jocn.1999.0192)
169. Susa S, Daimon M, Morita Y, Kitagawa M, Hirata A, Manaka H, Sasaki H & Kato T. Acute intermittent porphyria with central pontine myelinolysis and cortical laminar necrosis. Neuroradiology 1999 41 835-839. (doi:10.1007/ s002340050852)
170. Tuleja E, Chermann JF, Sereni C, Hart G & Sereni D. Kluver Bucy syndrome, unusual consequence of excessively rapid correction of severe hyponatremia. Presse Médicale 2008 37 975-977. (doi:10.1016/j.lpm.2007. 08.021)
171. Twardowschy CA, Bertolucci CB & Gracia Cde M. Pontine and extrapontine osmotic myelinolysis after the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with fluoxetine: case report. Arquivos de Neuro-Psiquiatria 2007 65 858-864. (doi:10.1590/S0004- 282X2007000500027)
172. West W, Gilbert DT & Wilks RJ. Central myelinolysis in a patient with hyponatraemia. West Indian Medical Journal 2007 56 382-384. (Pubitemid 350303460)
173. Wu Y-C, Peng G-S, Cheng C-A, Lin CC, Huang WS, Hsueh CJ & Lee JT. (99m)Tc-TRODAT-1 and (123)I-IBZM SPECT studies in a patient with extrapontine myelinolysis with parkinsonian features. Annals of Nuclear Medicine 2009 23 409-412. (doi:10.1007/s12149-009-0244-6)
174. Ziadi A, Nejmi H, Khallouki M, Younous S, Essaadouni L & Samkaoui MA. Centropontine myelinolysis and extrapontine myelinolysis complicating the quick correction of a hyponatremia. Annales Françaises d'Anesthésie- Réanimation 2009 28 714-715. (doi:10.1016/j.annfar.2009.05.010)
175. Burneo J, Vizcarra D & Miranda H. Central pontine myelinolysis and pregnancy: a case report and review of literature. Revista de Neurología 2000 30 1036-1040. (Pubitemid 30497556)
176. Sterns RH, Nigwekar SU & Hix JK. The treatment of hyponatremia. Seminars in Nephrology 2009 29 282-299. (doi:10.1016/j.semnephrol.2009.03.002)
177. Rozen-Zvi B, Yahav D, Gheorghiade M, Korzets A, Leibovici L & Gafter U. Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis. American Journal of Kidney Diseases 2010 56 325-337. (doi:10.1053/j.ajkd.2010.01.013)
178. Jaber BL, Almarzouqi L, Borgi L, Seabra VF, Balk EM & Madias NE. Short-term efficacy and safety of vasopressin receptor antagonists for treatment of hyponatremia. American Journal of Medicine 2011 124 971-979. (doi:10.1016/j.amjmed.2011.04.028)
179. Ghali JK, Koren MJ, Taylor JR, Brooks-Asplund E, Fan K, Long WA & Smith N. Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia. Journal of Clinical Endocrinology and Metabolism 2006 91 2145-2152. (doi:10.1210/jc.2005-2287)
180. Zeltser D, Rosansky S, van Rensburg RH, Verbalis JG, Smith N & Conivaptan Study Group. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia. American Journal of Nephrology 2007 27 447-457. (doi:10.1159/000106456)
181. Annane D, Decaux G, Smith N & Conivaptan Study G. Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia. American Journal of the Medical Sciences 2009 337 28-36. (doi:10.1097/MAJ.0b013e31817b8148)
182. Naidech AM, Paparello J, Leibling SM, Bassin SL, Levasseur K, Alberts MJ, Bernstein RA & Muro K. Use of Conivaptan (Vaprisol) for hyponatremic neuro-ICU patients. Neurocritical Care 2010 13 57-61. (doi:10.1007/s12028-010- 9379-5)
183. Koren MJ, Hamad A, Klasen S, Abeyratne A, McNutt BE & Kalra S. Efficacy and safety of 30-minute infusions of conivaptan in euvolemic and hypervolemic hyponatremia. [Erratum appears in Am J Health Syst Pharm. 2011 Aug 1;68(15):1374]. American Journal of Health-System Pharmacy 2011 68 818-827. (doi:10.2146/ajhp100260)
184. Gerbes AL, Gulberg V, Gines P, Decaux G, Gross P, Gandjini H, Djian J & VPA Study Group. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial. Gastroenterology 2003 124 933-939. (doi:10.1053/gast.2003.50143)
185. Wong F, Blei AT, Blendis LM & Thuluvath PJ. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial. Hepatology 2003 37 182-191. (doi:10.1053/jhep.2003.50021)
186. Abraham WT, Decaux G, Josiassen RC, Yagil Y, Kopyt N, Thacker HP, Mannelli M, Bichet DG, Orlandi C & HARMONY Study Group. Oral lixivaptan effectively increases serum sodium concentrations in outpatients with euvolemic hyponatremia. Kidney International 2012 82 8.
187. Abraham WT, Hensen J, Gross PA, Bichet DG, Josiassen RC, Chafekar DS, Orlandi C & LIBRA Study Group. Lixivaptan safely and effectively correctsserum concentrations in hospitalized patients with euvolemic hyponatremia. Kidney International 2012 82 8.
188. Bai S, Targum S & Thompson CJ. Combined clinical and statiscal review tolvaptan. U.S. Food and Drug Administration. Retrieved from: http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4373b1-02.pdf, 2008.
189. Soupart A, Gross P, Legros JJ, Alföldi S, Annane D, Heshmati HM & Decaux G. Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist. Clinical Journal of the American Society of Nephrology 2006 1 1154-1160. (doi:10.2215/CJN.00160106)
190. Decaux G. Long-term satavaptan treatment and drug holiday in patients with SIADH. Journal of the American Society of Nephrology 2008 19 588A.
191. Gines P, Wong F, Watson H, Milutinovic S, del Arbol LR, Olteanu D & HypoCAT Study Investigators. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial. Hepatology 2008 48 204-213. (doi:10.1002/hep.22293)
192. Aronson D. Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selectve arginine vasopressin V2-receptor antagonist: the DILIPO study. European Journal of Heart Failure 2011 13 327-336. (doi:10.1093/eurjhf/hfq226)
193. Gheorghiade M, Niazi I, Ouyang J, Czerwiec F, Kambayashi J, Zampino M, Orlandi C & Tolvaptan Investigators. Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. Circulation 2003 107 2690-2696. (doi:10.1161/01.CIR. 0000070422.41439.04)
194. Gheorghiade M, Gattis WA, O'Connor CM, Adams KF Jr, Elkayam U, Barbagelata A, Ghali JK, Benza RL, McGrew FA, Klapholz M et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. Journal of the American Medical Association 2004 291 1963-1971. (doi:10.1001/jama.291.16.1963)
195. Gheorghiade M, Gottlieb SS, Udelson JE, Konstam MA, Czerwiec F, Ouyang J, Orlandi C & Tolvaptan Investigators. Vasopressin v(2) receptor blockade with tolvaptan versus fluid restriction in the treatment of hyponatremia. American Journal of Cardiology 2006 97 1064-1067. (doi:10.1016/j.amjcard.2005. 10.050)
196. Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C & SALT Investigators. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. New England Journal of Medicine 2006 355 2099-2112. (doi:10.1056/NEJMoa065181)
197. Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. Journal of the American Medical Association 2007 297 1319-1331. (doi:10.1001/jama.297.12.1319)
198. Di Benedetto G & See M. Direct Healthcare Professional Communication on the risk of increases in serum sodium with tolvaptan (Samsca) which are too rapid. 2012. Available: http://www.mhra.gov.uk/home/groups/comms-ic/documents/ websiteresources/con146921.pdf. Accessed 08 May 2013.
199. Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. New England Journal of Medicine 2012 367 2407-2418. (doi:10.1056/NEJMoa1205511)
200. U.S. Food and Drug Administation. FDA Drug Safety Communication: FDA limits duration and usage of Samsca (tolvaptan) due to possible liver injury leading to organ transplant or death. 2013. Available: http://www.fda.gov/ downloads/Drugs/DrugSafety/UCM350084.pdf. Accessed 25 July 2013.
201. Alexander RC, Karp BI, Thompson S, Khot V & Kirch DG. A double blind, placebo-controlled trial of demeclocycline treatment of polydipsia-hyponatremia in chronically psychotic patients. Biological Psychiatry 1991 30 417-420. (doi:10.1016/0006-3223(91)90300-B)
202. Decaux G, Caroline A, Fabrice GK & Alain S. Treatment of euvolemic hyponatremia in the intensive care unit by urea. Critical Care 2010 14 R184. (doi:10.1186/cc9292)
203. Decaux G & Genette F. Urea for long-term treatment of syndrome of inappropriate secretion of antidiuretic hormone. BMJ 1981 283 1081-1083. (doi:10.1136/bmj.283.6299.1081)
204. Decaux G, Unger J, Brimioulle S & Mockel J. Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy. Journal of the American Medical Association 1982 247 471-474. (doi:10.1001/jama.1982. 03320290017021)
205. Reeder RF & Harbaugh RE. Administration of intravenous urea and normal saline for the treatment of hyponatremia in neurosurgical patients. Journal of Neurosurgery 1989 70 201-206. (doi:10.3171/jns.1989.70.2.0201)
206. Coussement J, Danguy C, Zouaoui-Boudjeltia K, Defrance P, Bankir L, Biston P & Piagnerelli M. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with urea in critically ill patients. American Journal of Nephrology 2012 35 265-270. (doi:10.1159/000336716)
207. Vieweg WV, Wilkinson EC, David JJ, Rowe WT, Hobbs WB & Spradlin WW. The use of demeclocycline in the treatment of patients with psychosis, intermittent hyponatremia, and polydipsia (PIP syndrome). Psychiatric Quarterly 1988 59 62-68. (doi:10.1007/BF01064293)
208. Hantman D, Rossier B, Zohlman R & Schrier R. Rapid correction of hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. An alternative treatment to hypertonic saline. Annals of Internal Medicine 1973 78 870-875. (doi:10.7326/0003-4819-78-6-870)
209. Decaux G, Przedborski S & Soupart A. Lack of efficacy of phenytoin in the syndrome of inappropriate anti-diuretic hormone secretion of neurological origin. Postgraduate Medical Journal 1989 65 456-458. (doi:10.1136/pgmj.65.765. 456)
210. Singhi SC, Singhi PD, Srinivas B, Narakesri HP, Ganguli NK, Sialy R & Walia BN. Fluid restriction does not improve the outcome of acute meningitis. Pediatric Infectious Disease Journal 1995 14 495-503. (doi:10.1097/00006454- 199506000-00006)
211. Kawai N, Ishikawa K, Nemoto K, Katano T, Takahashi S, Hori T & Asada T. Oral urea treatment for polydipsia-hyponatremia syndrome in patients with schizophrenia. Journal of Clinical Psychopharmacology 2009 29 499-501. (doi:10.1097/JCP.0b013e3181b3b38c)
212. Soupart A, Coffernils M, Couturier B, Gankam-Kengne F & Decaux G. Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH. Clinical Journal of the American Society of Nephrology 2012 7 742-747. (doi:10.2215/CJN.06990711)
213. Verhoeven A, Musch W & Decaux G. Treatment of the polydipsia-hyponatremia syndrome with urea. Journal of Clinical Psychiatry 2005 66 1372-1375. (doi:10.4088/JCP.v66n1105)
214. Carrilho F, Bosch J, Arroyo V, Mas A, Viver J & Rodes J. Renal failure associated with demeclocycline in cirrhosis. Annals of Internal Medicine 1977 87 195-197. (doi:10.7326/0003-4819-87-2-195)
215. De Troyer A. Demeclocycline. Treatment for syndrome of inappropriate antidiuretic hormone secretion. Journal of the American Medical Association 1977 237 2723-2726. (doi:10.1001/jama.1977.03270520033016)
216. Forrest JN Jr, Cox M, Hong C, Morrison G, Bia M & Singer I. Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone. New England Journal of Medicine 1978 298 173-177. (doi:10.1056/NEJM197801262980401)
217. Goldman MB & Luchins DJ. Demeclocycline improves hyponatremia in chronic schizophrenics. Biological Psychiatry 1985 20 1149-1155. (doi:10.1016/0006-3223(85)90172-6)
218. Perks WH, Walters EH, Tams IP & Prowse K. Demeclocycline in the treatment of the syndrome of inappropriate secretion of antidiuretic hormone. Thorax 1979 34 324-327. (doi:10.1136/thx.34.3.324)
219. Trump DL. Serious hyponatremia in patients with cancer: management with demeclocycline. Cancer 1981 47 2908-2912. (doi:10.1002/1097-0142(19810615)47: 12〈2908::AID-CNCR2820471228〉3.0.CO;2-R)
220. Vieweg WV, Weiss NM, David JJ, Rowe WT, Godleski LS & Spradlin WW. Treatment of psychosis, intermittent hyponatremia, and polydipsia (PIP syndrome) using lithium and phenytoin. Biological Psychiatry 1988 23 25-30. (doi:10.1016/0006-3223(88)90103-5)
221. Decaux G. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by long loop diuretics. Nephron 1983 35 82-88. (doi:10.1159/000183052)
222. Antonelli A, Carmassi F, Alberti B, Gambuzza C, Neri S, Saracino A & Baschieri L. Demeclocycline-induced phosphate diabetes in a patient with inappropriate ADH secretion and systemic sarcoidosis. Nephron 1993 63 226-229. (Pubitemid 23045251)
223. Boissonnas A, Casassus P, Caquet R & Laroche C. Hyponatremia in a cirrhotic suffering from late cutaneous porphyria: a drug to avoid, demeclocycline. La Nouvelle Presse Médicale 1979 8 210. (Pubitemid 9089014)
224. Cledes J, Clavier J & Kerbrat G. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with demethylchlortetracycline. Apropos of 2 cases. La Semaine des Hopitaux 1977 53 823-826. (Pubitemid 8074621)
225. Curtis NJ, van Heyningen C & Turner JJ. Irreversible nephrotoxicity from demeclocycline in the treatment of hyponatremia. Age and Ageing 2002 31 151-152. (doi:10.1093/ageing/31.2.151-a)
226. Danovitch GM, Le RD & Glick S. Renal function during treatment of inappropriate secretion of antidiuretic hormone with demeclocycline. Israel Journal of Medical Sciences 1978 14 852-857.
227. Decaux G, Soupart A, Unger J & Delwiche F. Demeclocycline-induced phosphate diabetes in patients with inappropriate secretion of antidiuretic hormone. New England Journal of Medicine 1985 313 1480-1481. (doi:10.1056/NEJM198512053132317)
228. Martin J, Codinach N, Conte-Devolx B & Gauthier A. Demethylchlortetracycline treatment of cirrhotic ascites with hyponatremia. La Nouvelle Presse Médicale 1977 6 1066.
229. Miller PD, Linas SL & Schrier RW. Plasma demeclocycline levels and nephrotoxicity. Correlation in hyponatremic cirrhotic patients. Journal of the American Medical Association 1980 243 2513-2515. (doi:10.1001/jama.1980. 03300500039026)
230. Padfield PL, Hodsman GP & Morton JJ. Demeclocycline in the treatment of the syndrome of inappropriate antidiuretic hormone release: with measurement of plasma ADH. Postgraduate Medical Journal 1978 54 623-627. (doi:10.1136/pgmj.54.635.623)
231. Pedrol E, Martos JA, Plaza V, Celis R & Montserrat JM. Acute pancreatitis caused by demeclocycline. Revista Clínica Española 1989 184 392-393. (Pubitemid 19263492)
232. 2 and kallikrein in hyponatremic cirrhotics. Nephron 1984 36 30-37. (doi:10.1159/000183112)
233. Youn KS & Tokeshi J. Therapy with hypertonic saline in combination with anti-convulsants for hyponatremia-induced seizure: a case report and review of the literature. Hawaii Medical Journal 2002 61 280-281.
234. Tanneau RS, Cledes J, Garo B, Boles JM, Islam MS & Garre M. Deleterious effect of prolonged sodium administration and fluid restriction after partial correction of severe hyponatremia. Critical Care Medicine 1991 19 305-306. (doi:10.1097/00003246-199102000-00043)
235. Wijdicks EF, Vermeulen M, Hijdra A & van Gijn J. Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful? Annals of Neurology 1985 17 137-140. (doi:10.1002/ana. 410170206)
236. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L & Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. Journal of the American Medical Association 2012 308 1566-1572. (doi:10.1001/jama.2012. 13356)
237. Fliser D, Laville M, Covic A, Fouque D, Vanholder R, Juillard L, Van Biesen W & Ad-hoc working group of ERBP. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathy. Nephrology, Dialysis, Transplantation 2012 27 4263-4272. (doi:10.1093/ndt/ gfs375)
238. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International 2012 2 s1-s138.
239. Perianayagam A, Sterns RH, Silver SM, Grieff M, Mayo R, Hix J & Kouides R. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clinical Journal of the American Society of Nephrology 2008 3 331-336. (doi:10.2215/CJN.03190807)
240. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011 64 401-406. (doi:10.1016/j.jclinepi.2010.07.015)
241. Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, Schünemann HJ & GRADE Working Group. Going from evidence to recommendations. BMJ 2008 336 1049-1051. (doi:10.1136/bmj.39493.646875.AE)
242. Janicic N & Verbalis JG. Evaluation and management of hypoosmolality in hospitalized patients. Endocrinology and Metabolism Clinics of North America 2003 32 459-481 (vii). (doi:10.1016/S0889-8529(03)00004-5)
243. Lindner G, Zapletal B, Schwarz C, Wisser W, Hiesmayr M & Lassnigg A. Acute hyponatremia after cardioplegia by histidine-tryptophane-ketoglutarate - a retrospective study. Journal of Cardiothoracic Surgery 2012 7 52. (doi:10.1186/1749-8090-7-52)
244. Sirken G, Raja R, Garces J, Bloom E & Fumo P. Contrast-induced translocational hyponatremia and hyperkalemia in advanced kidney disease. American Journal of Kidney Diseases 2004 43 e31-e35. (doi:10.1053/j.ajkd.2003. 10.028)
245. Palevsky PM, Rendulic D & Diven WF. Maltose-induced hyponatremia. Annals of Internal Medicine 1993 118 526-528. (doi:10.7326/0003-4819-118-7- 199304010-00007)
246. Vaswani SK & Sprague R. Pseudohyponatremia in multiple myeloma. Southern Medical Journal 1993 86 251-252. (doi:10.1097/00007611-199302000-00027)
247. Liamis G, Milionis H & Elisaf M. A review of drug-induces hyponatraemia. American Journal of Kidney Diseases 2008 52 144-153. (doi:10.1053/j.ajkd.2008.03.004)